CGP 51901: Tanox began its third trial of CGP 51901

Tanox Biosystems Inc., Houston, Texas Product: CGP 51901, anti-IgE monoclonal antibody Indication: Asthma Status: Tanox began its third trial of CGP 51901, which is being developed jointly with Ciba-G...